Feasibility Study of BMAC Enhanced CABG

Inclusion Criteria: * Age\> 18 years and ability to understand the planned treatment. * Patients with ischemic congestive heart failure requiring by pass surgery * Congestive heart failure with ejection fraction ≤ 40%. * Serum bilirubin, SGOT and SGPT ≤2.5 time the upper level of normal. * Serum creatinine \< 3.0 or no dialysis. * NYHA performance status ≥ 3. * Negative pregnancy test (in women with childbearing potential). * Subject has read and signed the IRB approved Informed Consent form * Hematocrit ≥ 28.0%, White Blood Cell count ≤ 14,000, Platelet count ≥ 50,000, Creatinine ≤ 3.0 mg / Dl, and/or no dialysis, INR ≤ 1.6 unless on Coumadin, or PTT \<1.5 x control (to avoid bleeding complications) Patients on Coumadin will be corrected prior to the procedure and must have an INR\<1.6 at the time of randomization/surgery Exclusion Criteria: * Female who is pregnant or nursing, or of child bearing potential and is not using a reliable birth control method, or who intend to become pregnant during the tenure of this study. * History of Prior Radiation Exposure for oncological treatment. * History of Bone Marrow Disorder (especially NHL, MDS) that prohibit transplantation. * History of abnormal Bleeding or Clotting. * History of Liver Cirrhosis. * Acute Myocardial Infarction \< 4 weeks from treatment date. * Known active malignancy or results outside of normal limits from the following tests: PAP, Chest X-ray, PSA, Mammogram, Hemoccult unless follow-up studies reveal patient…